Biogen will soon extend its contract pharmacy restrictions to non-hospital covered entities, while Novartis will require hospitals to submit claims [...] …
Articles by : Shannon Young, Associate Editor/Senior Writer
Washington state could see greater cost reductions under a Medicaid fee-for-service pharmacy reimbursement model for 340B providers than through Medicaid [...] …
Contract pharmacy restrictions—and legislation to override them—dominated 340B policy discussions in statehouses and courtrooms across the country this year, as [...] …
From drugmakers proposing new controversial 340B rebate models to federal lawmakers unveiling their first draft of a bipartisan-backed proposal to [...] …
U.S. Rep. Earl “Buddy” Carter (R-Ga.), a pharmacist who has advocated for major changes to the 340B program which many [...] …
U.S. House Republican leaders this week unveiled and then quickly backed off of a year-end federal spending package following internal [...] …
The 119th Congress’ House Energy and Commerce (E&C) Committee—an influential panel with jurisdiction over the Medicaid and 340B programs—will feature [...] …
A New Jersey congressman will again serve as the top Democrat on a key House committee, which has jurisdiction over [...] …
The West Virginia Board of Pharmacy is beginning to act on its growing backlog of alleged violations to the state’s [...] …
Provider groups, including those with large numbers of 340B covered entity members, this week lauded U.S. Rep. Brett Guthrie’s (R-Ky.) [...] …